#DYK? Patients living with #ShortBowelSyndrome (SBS) who are dependent on parenteral support face a higher risk of disabling and life-threatening complications. Our website for U.S. healthcare professionals (#HCPs), has more information about the challenges that many people living with SBS navigate daily. Learn more.? #RareDiseaseDay #ShortGut #ShowYourStripes https://ow.ly/lNza50V7NTt
Ironwood Pharmaceuticals
生物技术研究
Boston，MA 31,097 位关注者
Ironwood is on a mission to advance treatment of gastrointestinal diseases & redefine the standard of care for patients
关于我们
At Ironwood Pharmaceuticals, we are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients. As a pioneer and champion in the development of a market-leading therapy for IBS-C and CIC, we are singularly focused on advancing the treatment of GI diseases and continue to challenge what has been done before to shape what the future holds. So, we named ourselves after the Ironwood tree, which can live for thousands of years in the harshest desert, creating a shaded microclimate in which life thrives. Iron, like science, is undeniable and strong. Wood, like artistry and humanity, is flexible, resilient and versatile. The two words together represent our passion for making a positive impact on the health – and lives- of GI patients, their families and communities. Our core values: ?Transform Patient Lives: Leverage our insights, capabilities, and expertise to see the most critical patient needs. ?Innovate Meaningfully: Think boldly, experiment proactively, and take initiative to create new possibilities in the GI world. ?Challenge and Collaborate: Encourage different opinions and points of views in decision-making. ?Practice Humanity: Recognize that our people are the cornerstone of Ironwood. ?Own The Outcome: Honor our commitments to our patients, stakeholders, and one another by upholding a performance-driven culture.
- 网站
-
https://ironwoodpharma.com/
Ironwood Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Boston，MA
- 类型
- 上市公司
- 创立
- 1998
地点
-
主要
获取路线
100 Summer Street
US，MA，Boston，02110
Ironwood Pharmaceuticals员工
动态
-
Proud to share that our investigational glucagon-like peptide 2 (GLP-2) analog being developed for short bowel syndrome with intestinal failure (SBS-IF) was highlighted in Gastroenterology & Endoscopy News’ “Expert Picks: Best of ACG Part 1 of 2”. #ShortBowelSyndrome #GIHealth
-
-
On #NationalPharmacistDay, we celebrate the incredible contributions of Ironwood’s pharmacists who drive innovation and excellence in GI health. From ensuring patient safety and regulatory compliance to advancing medical strategies, our pharmacists play a vital role in improving outcomes for GI patients. Your dedication and expertise are at the heart of everything we do. Thank you for making a difference every day! #WorkingInGIHealth #Pharmacy
-
-
As the year draws to an end, we’re thankful for the partnership of the GI community and the dedication of Ironwoodians to advancing the treatment of #GI diseases and redefining the standard of #digestivehealth care. Wishing everyone #HappyNewYear! Here’s to a great 2025! #WorkinginGIHealth
-
-
#DYK? There are approximately 12,000 patients in the US living with #shortbowelsyndrome (SBS) who are dependent on #parenteralsupport. Visit our website designed for US health care professionals, for more information: https://ow.ly/GnKu50UsRyO #digestivehealth #WorkinginGIHealth
-
-
Ironwoodian, Jeff Henderson recently spoke at Informa Connect's Trade & Channel Strategies event. Jeff discussed strategies for competitive product positioning and #payer engagement in the #pharma industry. Thanks for sharing your expertise, Jeff! #WorkinginGIHealth
-
-
Congratulations to Ironwoodian, Elizabeth Amstutz, who was recently promoted to Vice President, Head of Global Regulatory Affairs. Elizabeth brings over 19 years of industry experience leading global teams and projects within #biopharmaceutical companies. She is passionate about developing her teams and establishing and executing novel regulatory strategies to accelerate #drugdevelopment. Outside of work, Elizabeth loves reading, hiking, traveling and spending time with her family and friends. She lives in Zurich with her husband and three children. Join us in congratulating Elizabeth and wishing her success in the new role! #WorkinginGIHealth
-
#DYK the most common symptoms of chronic idiopathic #constipation (#CIC) and #IBS-C? If these symptoms are all too familiar for you, talk to your healthcare provider to learn more about treatment options available to you. #constipationawarenessmonth #WorkinginGIHealth #digestivehealth
-
We’re looking forward to #ASH24 in San Diego! We’ll be presenting findings from STARGAZE, a Phase II study of our investigational glucagon-like peptide 2 (GLP-2) agonist in patients with steroid-refractory gastrointestinal acute Graft-Versus-Host Disease (#aGvHD). We hope to see you there! #WorkinginGIHealth
-